Pentobarbital will lessen the extent or influence of voriconazole by impacting hepatic enzyme CYP2C9/ten metabolism. Minimal/Importance Unfamiliar. Contraindicated (1)pentobarbital will decrease the extent or influence of cobimetinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Steer clear of coadministration. Strong or average CYP3A inducers may well low... https://eddies232shu8.thekatyblog.com/profile